Yahoo! Finance Search - Finance Home - Yahoo! - Help

Saturday, January 21 2017 6:32pm ET - U.S. Markets Closed.
Industry Center - Diagnostic Substances
Industry Center > Diagnostic Substances > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Diagnostic Substances News
Latest News
Wednesday, Jan 18, 2017
·IDEXX Laboratories to Release 2016 Fourth Quarter and Full-Year Financial Results
PR Newswire - Wed Jan 18
Tuesday, Jan 17, 2017
·Chembio’s DPP® HIV-Syphilis Assay Receives CE Mark for Simultaneous Point-of-Care Detection of HIV and Syphilis
GlobeNewswire - Tue Jan 17
Friday, Jan 13, 2017
·U.S. Pet Care Spending Has Grown 60% Since 2006 (WOOF, IDXX)
at Investopedia - Fri Jan 13
Thursday, Jan 12, 2017
·Microbix Appoints Meridian Life Science as Distributor in Asia Pacific
Marketwire - Thu Jan 12
Wednesday, Jan 11, 2017
·The Top 200 IVD Companies Worldwide
PR Newswire - Wed Jan 11
·Palatin Technologies to Hold Call Following Closing of Licensing Agreement for North American Rights to Rekynda™
PR Newswire - Tue Jan 10
Tuesday, Jan 10, 2017
·Chembio Completes Acquisition of Malaysia-based RVR Diagnostics
GlobeNewswire - Tue Jan 10
Monday, Jan 9, 2017
·Bioline Launches the Full Range of EPIK(TM) miRNA Assays
Thomson Reuters ONE - Mon Jan 9
·Bioline Launches the Full Range of EPIK™ miRNA Assays
GlobeNewswire - Mon Jan 9
·Mars Makes 'Breakthrough Deal' With VCA Acquisition: More Squawk From Jim Cramer
at TheStreet.com - Mon Jan 9
·Vermillion Announces Reimbursement Code Updates for Overa and OVA1
PR Newswire - Mon Jan 9
·Atossa Genetics Provides Update on its Phase 2 Study of Fulvestrant Administered with its Microcatheter
Marketwire - Mon Jan 9
·AMAG Pharmaceuticals Provides Financial and Business Update
GlobeNewswire - Mon Jan 9
·AMAG Pharmaceuticals and Palatin Technologies Enter Into Exclusive Licensing Agreement for North American Rights to Rekynda™ (bremelanotide), a Potential Treatment for a Common Female Sexual Disorder
GlobeNewswire - Mon Jan 9
·AMAG Pharmaceuticals and Palatin Technologies Enter Into Exclusive Licensing Agreement for North American Rights to Rekyndatm (bremelanotide), a Potential Treatment for a Common Female Sexual Disorder
GlobeNewswire - Mon Jan 9
Saturday, Jan 7, 2017
·Quidel Announces Preliminary Revenue for Fourth Quarter 2016
Marketwire - Fri Jan 6
Friday, Jan 6, 2017
·Bragar Eagel & Squire, P.C. Is Investigating Trinity Biotech plc (TRIB) on Behalf of Stockholders and Encourages Investors to Contact the Firm
Business Wire - Thu Jan 5
·Atossa Genetics to Present at the 9th Annual Biotech Showcase Conference on January 9, 2017
Marketwire - Thu Jan 5
Thursday, Jan 5, 2017
·Vermillion and ASPiRA LABS Announce Receipt of Formal FDA Clarification Regarding Ovarian Cancer Screening Alert
PR Newswire - Wed Jan 4
Wednesday, Jan 4, 2017
·Maine-based Idexx joins S&P 500 index
AP - Wed Jan 4
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Diagnostic Substances Headlines
More Finance RSS Feeds


Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2017 Morningstar, Inc. All Rights Reserved. Company information © 2017 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2017, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?